Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03800758 · ClinicalTrials.gov registry record · Phase 3
Expressive Helping for Stem Cell Transplant Patients
A Phase 3 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 3
- Development phase
- 405
- Enrollment target
NCT03800758 is a Phase 3 study that has completed, run by Northwestern University. The registered enrollment target is 405 participants.
The verdict
NCT03800758, a Phase 3 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 405 participants
- Enrollment target
Study Summary
The Writing for Insight, Strength, and Ease (WISE) Study is a multisite Randomized Controlled Trial (RCT) testing the efficacy of the Expressive Helping (EH) intervention among adults receiving hematopoietic stem cell transplantation.
Interventions
- BEHAVIORAL Expressive Helping
- BEHAVIORAL Factual Writing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 405 participants |
| Start Date | 2019-03-06 |
| Est. Completion | 2023-04-24 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03800758
The ClinicalTrials.gov registry entry for NCT03800758 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 405 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Expressive Helping is the first listed.
NCT03800758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03800758 about?
NCT03800758 is a clinical study titled "Expressive Helping for Stem Cell Transplant Patients". The Writing for Insight, Strength, and Ease (WISE) Study is a multisite Randomized Controlled Trial (RCT) testing the efficacy of the Expressive Helping (EH) intervention among adults receiving hematopoietic stem cell transplantation.
What is the current status of trial NCT03800758?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 405 participants. The study started on 2019-03-06. Estimated completion is 2023-04-24.
What interventions are being tested in trial NCT03800758?
The interventions under investigation include: Expressive Helping (BEHAVIORAL), Factual Writing (BEHAVIORAL).
Who is sponsoring clinical trial NCT03800758?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.